Pictured: Jedd Wolchok
MSK at ASCO
By Media Staff  |  Wednesday, June 4, 2014

Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer.

Pictured: Helen McArthur
In the Clinic
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, June 3, 2014

The treatment combines a technique called cryoablation, or freezing of the tumor, with an immunotherapy drug.

Pictured: David Solit
Profile
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, May 27, 2014

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

Pictured: Tari King
In the News
By Jennifer Bassett, MA, Writer/Editor  |  Thursday, May 22, 2014

Memorial Sloan Kettering breast surgeon Tari King talks to CBS Online about a new study suggesting double mastectomies may be performed unnecessarily in many women.

Pictured: Mark Kris
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, May 21, 2014

A new study has found that driver mutations can be found in about two-thirds of lung adenocarcinomas, suggesting options for treatment with targeted therapies.

Pictured: José Baselga, Agnès Viale,  Michael Berger & David Solit
Announcement
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, May 20, 2014

With the creation of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering sets out to deliver on the promise of personalized medicine by creating better treatment options for all people with cancer.

pictured: Martin S. Tallman
Profile
By Maureen Salamon, BA, Freelance Writer  |  Monday, May 19, 2014

Leukemia Specialist Martin Tallman discusses how research has led to improvements in the treatment of leukemia and what challenges remain.

Pictured: William Tap
MSK at ASCO
By Media Staff  |  Thursday, May 15, 2014

New Memorial Sloan Kettering research demonstrates the powerful clinical benefit of giving patients a drug that targets the molecular abnormality driving the growth of a rare and debilitating joint disease.

Pictured: Dean Bajorin
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Wednesday, May 7, 2014

Each year, hundreds of people choose Memorial Sloan Kettering for diagnosis and treatment of bladder cancer.

Pictured: Kenneth Offit
Q&A
By Andrea Peirce, BA, Writer/Editor  |  Monday, May 5, 2014

Memorial Sloan Kettering Clinical Genetics Service Chief Kenneth Offit discusses ways for women to clearly assess their risk for breast and ovarian cancers.

Pictured: Jedd Wolchok
In the News
By Jim Stallard, MA, Writer/Editor  |  Friday, May 2, 2014

Memorial Sloan Kettering physician-scientist Jedd Wolchok describes striking advances in cancer immunotherapy in New York Times and Scientific American.

Pictured: Stephen Solomon
Profile
By Celia Gittelson, BA  |  Tuesday, April 29, 2014

Interventional Radiology Service Chief Stephen Solomon leads a team of physicians who use image guidance to perform minimally invasive procedures for cancer diagnosis and treatment.

Pictured: Michelle Bradbury
Q&A
By Jim Stallard, MA, Writer/Editor  |  Thursday, April 24, 2014

A new optical-imaging approach could enable surgeons to more precisely visualize cancerous tissue during an operation.

In the News
By Jennifer Bassett, MA, Writer/Editor  |  Tuesday, April 22, 2014

Robin Roberts is joined on Good Morning America by Sergio Giralt, Chief of the Adult Bone Marrow Transplantation Service.

Cancer Guide
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, April 17, 2014

Molecular analysis of lung tumors can help guide treatment decisions. Memorial Sloan Kettering is one of only a handful of centers nationwide to offer this personalized approach to care.

Center News

Stay Informed

Get the latest information about cancer care and research every month.